
25 Feb 2022
PANMURE: Faron Pharmaceuticals : Clearer clinical strategy but extended timeline
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
PANMURE: Faron Pharmaceuticals : Clearer clinical strategy but extended timeline
Faron Pharmaceuticals Oy (FARN:LON) | 205 0 0.0% | Mkt Cap: 229.5m
- Published:
25 Feb 2022 -
Author:
Dr Mike Mitchell | Dr Julie Simmonds -
Pages:
13 -